FAM23B Inhibitors
FAM23B inhibitors constitute a unique class of chemical compounds designed to selectively impede the biological function of the FAM23B protein. The FAM23B protein, encoded by the FAM23B gene, plays a critical role in certain cellular processes, although the full extent of its functions may not be exhaustively characterized. The inhibitors targeting this protein are developed based on the understanding of the protein's involvement in specific cellular signaling pathways. These compounds operate by binding to the active site or other key domains of the FAM23B protein, effectively blocking its interaction with other cellular components and thus inhibiting its function. The design of these inhibitors is often informed by the structural analysis of FAM23B, enabling the creation of molecules that fit precisely within its active regions. By obstructing the protein's activity, these inhibitors can alter the downstream signaling events in which FAM23B is a critical player.
The biochemical mechanism of action of FAM23B inhibitors is typically rooted in their ability to interfere with the protein's normal activity within the cell. The specific signaling pathways or biological processes that FAM23B is involved with are considered when developing these inhibitors. By targeting such pathways, FAM23B inhibitors can exert their effects indirectly on the protein's activity, leading to a decrease in its functional output. For instance, if FAM23B is implicated in pathways that govern cell division or stress responses, the inhibitors might be designed to disrupt those specific molecular cascades. The selectivity of these inhibitors is crucial, as it ensures minimal off-target effects, which is particularly important for maintaining cellular homeostasis. FAM23B inhibitors, therefore, represent a focused approach to modulating the protein's activity, with a deep understanding of the molecular underpinnings that govern its role within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and together they inhibit mTOR, which is a downstream regulator of FAM23B. This inhibition can decrease the phosphorylation and activation of FAM23B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which is upstream of the Akt pathway. By inhibiting PI3K, LY294002 reduces Akt activation, which consequently decreases the functional activity of FAM23B due to reduced phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor which acts upstream of Akt, similar to LY294002. By inhibiting PI3K, wortmannin can decrease the phosphorylation state of downstream targets including FAM23B. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine specifically inhibits the activation of Akt, a kinase that would normally phosphorylate and activate FAM23B, thus indirectly inhibiting FAM23B activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which acts upstream of ERK. ERK has been implicated in the regulation of a variety of proteins, including FAM23B. By inhibiting ERK phosphorylation, PD98059 can reduce FAM23B activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which may modulate proteins like FAM23B. By inhibiting JNK, SP600125 might reduce the functional activity of FAM23B if JNK is involved in its regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2, which are upstream of ERK in the MAPK pathway. By inhibiting these kinases, U0126 can lead to a decrease in ERK-mediated phosphorylation of proteins like FAM23B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which can alter downstream signaling affecting proteins regulated by p38, potentially including FAM23B if it's within this pathway's scope. | ||||||
A-443654 | 552325-16-3 | sc-507339 | 1 mg | $140.00 | ||
A-443654 is an Akt inhibitor. Inhibiting Akt can lead to reduced phosphorylation and activation of downstream proteins, potentially including FAM23B if it is a target of Akt signaling. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
PP242 is an mTOR inhibitor that works differently from rapamycin. It inhibits both mTORC1 and mTORC2, leading to a broader reduction in mTOR pathway signaling and potentially affecting FAM23B activity. | ||||||